This is the comment from Paul Brennan in the US market entry announcement. If there is latent demand it shouldn`t take too long for meaningful sales.
“Taking direct control of our destiny is a significant step for the growth of PolyNovo. The US is the largest reimbursed dermal matrix market and surgeons have good product awareness and we believe a latent demand of the BTM. Our clinical trial programs have also established good relationships with key opinion leaders, enabling our sales team to identify clear market entry opportunities”.
- Forums
- ASX - By Stock
- PNV
- New article... a world first
New article... a world first, page-11
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.54 |
Change
0.110(4.53%) |
Mkt cap ! $1.746B |
Open | High | Low | Value | Volume |
$2.46 | $2.57 | $2.46 | $2.928M | 1.161M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 9352 | $2.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.55 | 22580 | 45 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 24209 | 2.540 |
14 | 40798 | 2.530 |
18 | 92536 | 2.520 |
15 | 163621 | 2.510 |
17 | 190266 | 2.500 |
Price($) | Vol. | No. |
---|---|---|
2.550 | 15521 | 41 |
2.560 | 86103 | 17 |
2.570 | 68087 | 14 |
2.580 | 57736 | 12 |
2.590 | 167819 | 7 |
Last trade - 15.56pm 12/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |